Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Stefan Zeuzem

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Hepacivirus

Procedures

Concepts & Ideas

Physiology

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
72
Sarrazin, Christoph
48
Herrmann, Eva
40
Piiper, Albrecht
36
Raedle, Jochen
35
Kronenberger, Bernd
35
Roth, Kurt
34
Caspary, Wolfgang
27
Trojan, Joerg
25
Teuber, Gerlinde
24
Berg, Thomas
22
von Wagner, Michael
21
Hofmann, Wolf Peter
19
Stryjek-Kaminska, D
18
Brieger, Angela
17
Rüster, Brigitte

Sign-in to see all Coauthors

Publications

TOP 3
Farnik Harald; El-Duweik Juliane; Welsch Christoph; Sarrazin Christoph; Lötsch Jörn; Zeuzem Stefan; Geisslinger Gerd; Schmidt Helmut
Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MS.
Akoglu Bora; Kriener Susanne; Martens Swantje; Herrmann Eva; Hofmann Wolf Peter; Milovic Vladan; Zeuzem Stefan; Faust Dominik
Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients.
Waidmann Oliver; Pleli Thomas; Dvorak Karel; Baehr Christina; Mondorf Ulrich; Plotz Guido; Biondi Ricardo M; Zeuzem Stefan; Piiper Albrecht
Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic products.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stefan Zeuzem (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Farnik Harald; El-Duweik Juliane; Welsch Christoph; Sarrazin Christoph; Lötsch Jörn; Zeuzem Stefan; Geisslinger Gerd; Schmidt Helmut
Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MS.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(31):4001-6.
2009: Akoglu Bora; Kriener Susanne; Martens Swantje; Herrmann Eva; Hofmann Wolf Peter; Milovic Vladan; Zeuzem Stefan; Faust Dominik
Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients.
Clinical and experimental medicine 2009;9(4):259-62.
2009: Waidmann Oliver; Pleli Thomas; Dvorak Karel; Baehr Christina; Mondorf Ulrich; Plotz Guido; Biondi Ricardo M; Zeuzem Stefan; Piiper Albrecht
Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic products.
The Journal of biological chemistry 2009;284(47):32256-63.
2009: Friedrich-Rust M; Schwarz A; Ong M; Dries V; Schirmacher P; Herrmann E; Samaras P; Bojunga J; Bohle R M; Zeuzem S; Sarrazin C
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2009;30(5):478-84.
2009: Lange C M; Hofmann W P; Kriener S; Jacobi V; Welsch C; Just-Nuebling G; Zeuzem S
Primary actinomycosis of the liver mimicking malignancy.
Zeitschrift für Gastroenterologie 2009;47(10):1062-4.
2009: Blumenstein I; Bock H; Zosel C; Dignass A U; Hartmann F; Zeuzem S; Stein J M; Schroeder O
[Are there gender-related differences in the therapeutic management of patients suffering from inflammatory bowel disease? Subgroup analysis of a prospective multicentre online-based trial]
Zeitschrift für Gastroenterologie 2009;47(10):1045-51.
2009: Dettori Rosalia; Sonzogni Silvina; Meyer Lucas; Lopez-Garcia Laura A; Morrice Nick A; Zeuzem Stefan; Engel Matthias; Piiper Albrecht; Neimanis Sonja; Frödin Morten; Biondi Ricardo M
Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1).
The Journal of biological chemistry 2009;284(44):30318-27.
2009: Hindie Valerie; Stroba Adriana; Zhang Hua; Lopez-Garcia Laura A; Idrissova Leila; Zeuzem Stefan; Hirschberg Daniel; Schaeffer Francis; Jørgensen Thomas J D; Engel Matthias; Alzari Pedro M; Biondi Ricardo M
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.
Nature chemical biology 2009;5(10):758-64.
2009: Zeuzem Stefan
Forewarned is forearmed.
Journal of hepatology 2009;51(4):626-7.
2009: Friedrich-Rust Mireen; Wunder Katrin; Kriener Susanne; Sotoudeh Fariba; Richter Swantje; Bojunga Joerg; Herrmann Eva; Poynard Thierry; Dietrich Christoph F; Vermehren Johannes; Zeuzem Stefan; Sarrazin Christoph
Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.
Radiology 2009;252(2):595-604.
2009: Berg Thomas; Weich Viola; Teuber Gerlinde; Klinker Hartwig; Möller Bernd; Rasenack Jens; Hinrichsen Holger; Gerlach Tilman; Spengler Ulrich; Buggisch Peter; Balk Heike; Zankel Myrga; Neumann Konrad; Sarrazin Christoph; Zeuzem Stefan
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.
Hepatology (Baltimore, Md.) 2009;50(2):369-77.
2009: Kronenberger Bernd; Zeuzem Stefan
Occludin a new HCV entry factor: is the list of essential hepatitis C virus receptors complete?
Gastroenterology 2009;137(2):727-8.
2009: Wedemeyer Heiner; Schuller Elisabeth; Schlaphoff Verena; Stauber Rudolf E; Wiegand Johannes; Schiefke Ingolf; Firbas Christa; Jilma Bernd; Thursz Mark; Zeuzem Stefan; Hofmann Wolf P; Hinrichsen Holger; Tauber Erich; Manns Michael P; Klade Christoph S
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Vaccine 2009;27(37):5142-51.
2009: Albert J G; Lübbert C; Surow A; Zeuzem S
[Small bowel diverticula - unknown disease]
Zeitschrift für Gastroenterologie 2009;47(7):674-81.
2009: Neumann Avidan U; Pianko Stephen; Zeuzem Stefan; Yoshida Eric M; Benhamou Yves; Mishan Moshe; McHutchison John G; Pulkstenis Erik; Mani Subramanian G
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C.
Journal of hepatology 2009;51(1):21-8.
2009: Zeuzem Stefan; Gane Edward; Liaw Yun-Fan; Lim Seng G; DiBisceglie Adrian; Buti Maria; Chutaputti Anuchit; Rasenack Jens; Hou Jinlin; O'Brien Christopher; Nguyen Tuan T; Jia Jidong; Poynard Thierry; Belanger Bruce; Bao Weibin; Naoumov Nikolai V
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.
Journal of hepatology 2009;51(1):11-20.
2009: Deterding K; Wiegand J; Grüner N; Hahn A; Jäckel E; Jung M C; Buggisch P; Galle P; Berg T; Hinrichsen H; Potthoff A; Zeuzem S; Cornberg M; Manns M; Wedemeyer H
The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.
Zeitschrift für Gastroenterologie 2009;47(6):531-40.
2009: Preiss J C; Blumenstein I; Zeuzem S; Zeitz M
[The state of health care and health care paths in inflammatory bowel disease (Crohn's disease and ulcerative colitis)]
Zeitschrift für Gastroenterologie 2009;47(6):529-30.
2009: Penna-Martinez Marissa; Ramos-Lopez Elizabeth; Stern Julienne; Hinsch Nora; Hansmann Martin-Leo; Selkinski Ivan; Grünwald Frank; Vorländer Christian; Wahl Robert A; Bechstein Wolf O; Zeuzem Stefan; Holzer Katharina; Badenhoop Klaus
Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2009;19(6):623-8.
2009: Hofmann Wolf P; Zeuzem Stefan
Hepatitis C: new therapeutic strategies needed for advanced disease.
Nature reviews. Gastroenterology & hepatology 2009;6(6):325-7.
2009: Zimmer V; Feiden W; Becker G; Zimmer A; Reith W; Raedle J; Lammert F; Zeuzem S; Hirano M; Menges M
Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2009;21(6):627-31.
2009: Pachiadakis Ioannis; Chokshi Shilpa; Cooksley Helen; Farmakiotis Dimitrios; Sarrazin Christoph; Zeuzem Stefan; Michalak Tomasz I; Naoumov Nikolai V
Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.
Clinical immunology (Orlando, Fla.) 2009;131(3):415-25.
2009: Sroczynski Gaby; Esteban Eva; Conrads-Frank Annette; Schwarzer Ruth; Mühlberger Nikolai; Wright Davene; Zeuzem Stefan; Siebert Uwe
Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
European journal of public health 2009;19(3):245-53.
2009: Friedrich-Rust Mireen; Zeuzem Stefan
Reproducibility and limitations of transient elastography.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(5):619-20.
2009: Vogl T J; Zeuzem S; Zangos S; Hammerstingl R
[Magnetic resonance cholangiopancreatography (MRCP) from a radiological and gastroenterological perspective]
Deutsche medizinische Wochenschrift (1946) 2009;134(19):1011-4.
2009: Kronenberger Bernd; Zeuzem Stefan
Current and future treatment options for HCV.
Annals of hepatology : official journal of the Mexican Association of Hepatology 2009;8(2):103-12.
2009: Hézode Christophe; Forestier Nicole; Dusheiko Geoffrey; Ferenci Peter; Pol Stanislas; Goeser Tobias; Bronowicki Jean-Pierre; Bourlière Marc; Gharakhanian Shahin; Bengtsson Leif; McNair Lindsay; George Shelley; Kieffer Tara; Kwong Ann; Kauffman Robert S; Alam John; Pawlotsky Jean-Michel; Zeuzem Stefan;
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
The New England journal of medicine 2009;360(18):1839-50.
2009: Hofmann Wolf Peter; Zeuzem Stefan
Advanced chronic hepatitis C: how to handle if you cannot halt?
Hepatology (Baltimore, Md.) 2009;49(4):1385-7.
2009: Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Journal of viral hepatitis 2009;16(3):168-77.
2009: Meyer Claus; Brieger Angela; Plotz Guido; Weber Nicole; Passmann Sandra; Dingermann Theo; Zeuzem Stefan; Trojan Joerg; Marschalek Rolf
An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome family.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):762-9.
2009: von Wagner M; Zeuzem S
[Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients]
Deutsche medizinische Wochenschrift (1946) 2009;134(6):255-8.
2009: Kronenberger Bernd; Zeuzem Stefan
Treatment of chronic hepatitis C: anticipated impact of resistance in patients treated with protease inhibitors.
Current gastroenterology reports 2009;11(1):15-21.
2009: Soriano Vincent; Peters Marion G; Zeuzem Stefan
New therapies for hepatitis C virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(3):313-20.
2009: Welker Martin-Walter; Zeuzem Stefan
Occult hepatitis C: how convincing are the current data?
Hepatology (Baltimore, Md.) 2009;49(2):665-75.
2009: Reddy K Rajender; Nelson David R; Zeuzem Stefan
Ribavirin: current role in the optimal clinical management of chronic hepatitis C.
Journal of hepatology 2009;50(2):402-11.
2009: Liaw Yun-Fan; Gane Edward; Leung Nancy; Zeuzem Stefan; Wang Yuming; Lai Ching Lung; Heathcote E Jenny; Manns Michael; Bzowej Natalie; Niu Junqi; Han Steven-Huy; Hwang Seong Gyu; Cakaloglu Yilmaz; Tong Myron J; Papatheodoridis George; Chen Yagang; Brown Nathaniel A; Albanis Efsevia; Galil Karin; Naoumov Nikolai V;
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
Gastroenterology 2009;136(2):486-95.
2009: Zeuzem S; Berg T; Moeller B; Hinrichsen H; Mauss S; Wedemeyer H; Sarrazin C; Hueppe D; Zehnter E; Manns M P
Expert opinion on the treatment of patients with chronic hepatitis C.
Journal of viral hepatitis 2009;16(2):75-90.
2009: Farnik Harald; Mihm Ulrike; Zeuzem Stefan
Optimal therapy in genotype 1 patients.
Liver international : official journal of the International Association for the Study of the Liver 2009;29 Suppl 1():23-30.
2009: Mihm Ulrike; Ackermann Oliver; Welsch Christoph; Herrmann Eva; Hofmann Wolf Peter; Grigorian Natalia; Welker Martin Walter; Lengauer Thomas; Zeuzem Stefan; Sarrazin Christoph
Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C.
Journal of hepatology 2009;50(1):49-58.
2009: Adiwijaya Bambang S; Hare Brian; Caron Paul R; Randle John Cr; Neumann Avidan U; Reesink Hendrik W; Zeuzem Stefan; Herrmann Eva
Rapid decrease of wild-type hepatitis C virus on telaprevir treatment.
Antiviral therapy 2009;14(4):591-5.
2009: Zeuzem Stefan; Rizzetto Mario; Ferenci Peter; Shiffman Mitchell L
Management of hepatitis C virus genotype 2 or 3 infection: treatment optimization on the basis of virological response.
Antiviral therapy 2009;14(2):143-54.
2009: Mühlberger Nikolai; Schwarzer Ruth; Lettmeier Beate; Sroczynski Gaby; Zeuzem Stefan; Siebert Uwe
HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.
BMC public health 2009;9():34.
2009: Hofmann Wolf Peter; Soriano Vincent; Zeuzem Stefan
Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Handbook of experimental pharmacology 2009;(189):321-46.
2008: Hofmann Wolf Peter; Herrmann Eva; Sarrazin Christoph; Zeuzem Stefan
Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(10):1332-43.
2008: Friedrich-Rust Mireen; Schneider Guenther; Bohle Rainer M; Herrmann Eva; Sarrazin Christoph; Zeuzem Stefan; Bojunga Joerg
Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions.
AJR. American journal of roentgenology 2008;191(6):1852-60.
2008: Teuber Gerlinde; Schäfer Arne; Rimpel Jasmin; Paul Kathrin; Keicher Christian; Scheurlen Michael; Zeuzem Stefan; Kraus Michael R
Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.
Journal of hepatology 2008;49(6):923-9.
2008: Vermehren Johannes; Kau Annika; Gärtner Barbara C; Göbel Reinhild; Zeuzem Stefan; Sarrazin Christoph
Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
Journal of clinical microbiology 2008;46(12):3880-91.
2008: Hofmann W P; Rädle J; Moench C; Bechstein W; Zeuzem S
[Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests]
Zeitschrift für Gastroenterologie 2008;46(11):1283-9.
2008: von Wagner Michael; Hofmann Wolf Peter; Teuber Gerlinde; Berg Thomas; Goeser Tobias; Spengler Ulrich; Hinrichsen Holger; Weidenbach Hans; Gerken Guido; Manns Michael; Buggisch Peter; Herrmann Eva; Zeuzem Stefan
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.
Hepatology (Baltimore, Md.) 2008;48(5):1404-11.
2008: Zeuzem Stefan
Interferon-based therapy for chronic hepatitis C: current and future perspectives.
Nature clinical practice. Gastroenterology & hepatology 2008;5(11):610-22.
2008: Hofmann W P; Kronenberger B; Bojunga J; Stamm B; Herrmann E; Bücker A; Mihm U; von Wagner M; Zeuzem S; Sarrazin C
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.
Journal of viral hepatitis 2008;15(11):790-6.
2008: Potthoff Andrej; Wedemeyer Heiner; Boecher Wulf O; Berg Thomas; Zeuzem Stefan; Arnold Joachim; Spengler Ulrich; Gruengreiff Kurt; Kaeser Thomas; Schuchmann Marcus; Bergk Alexandra; Forestier Nicole; Deterding Katja; Manns Michael P; Trautwein Christian;
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
Journal of hepatology 2008;49(5):688-94.
2008: Sarrazin Christoph; Dragan Anette; Gärtner Barbara C; Forman Michael S; Traver Stella; Zeuzem Stefan; Valsamakis Alexandra
Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2008;43(2):162-8.
2008: Lettmeier Beate; Mühlberger Nikolai; Schwarzer Ruth; Sroczynski Gaby; Wright Davene; Zeuzem Stefan; Siebert Uwe
Market uptake of new antiviral drugs for the treatment of hepatitis C.
Journal of hepatology 2008;49(4):528-36.
2008: Raedle-Hurst Tanja M; Welsch Christoph; Forestier Nicole; Kronenberger Bernd; Hess Georg; Herrmann Eva; Zeuzem Stefan; Raedle Jochen
Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease.
European journal of gastroenterology & hepatology 2008;20(9):865-73.
2008: Trojan J; Lubomierski N; Lehnert T; Engels K; Zeuzem S; Bechstein W O
Neoadjuvant treatment with cetuximab, 5-Fluorouracil, folinic Acid and oxaliplatin in unresectable retroperitoneal recurrent colon cancer.
Zeitschrift für Gastroenterologie 2008;46(8):776-9.
2008: Zeuzem Stefan; Yoshida Eric M; Benhamou Yves; Pianko Stephen; Bain Vincent G; Shouval Daniel; Flisiak Robert; Rehak Vratislav; Grigorescu Mircea; Kaita Kelly; Cronin Patrick W; Pulkstenis Erik; Subramanian G Mani; McHutchison John G
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C.
Hepatology (Baltimore, Md.) 2008;48(2):407-17.
2008: Kronenberger Bernd; Welsch Christoph; Forestier Nicole; Zeuzem Stefan
Novel hepatitis C drugs in current trials.
Clinics in liver disease 2008;12(3):529-55, viii.
2008: Zeuzem Stefan
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
Journal of hepatology 2008;49(2):157-9.
2008: Llovet Josep M; Ricci Sergio; Mazzaferro Vincenzo; Hilgard Philip; Gane Edward; Blanc Jean-Frédéric; de Oliveira Andre Cosme; Santoro Armando; Raoul Jean-Luc; Forner Alejandro; Schwartz Myron; Porta Camillo; Zeuzem Stefan; Bolondi Luigi; Greten Tim F; Galle Peter R; Seitz Jean-François; Borbath Ivan; Häussinger Dieter; Giannaris Tom; Shan Minghua; Moscovici Marius; Voliotis Dimitris; Bruix Jordi;
Sorafenib in advanced hepatocellular carcinoma.
The New England journal of medicine 2008;359(4):378-90.
2008: Herrmann Eva; Zeuzem Stefan
Ribavirin plus either peginterferon alpha-2a or peginterferon alpha-2b for patients with chronic HCV infection?
Nature clinical practice. Gastroenterology & hepatology 2008;5(7):362-3.
2008: Veldt Bart J; Chen Wendong; Heathcote E Jenny; Wedemeyer Heiner; Reichen Juerg; Hofmann W Peter; de Knegt Robert J; Zeuzem Stefan; Manns Michael P; Hansen Bettina E; Schalm Solko W; Janssen Harry L A
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
Hepatology (Baltimore, Md.) 2008;47(6):1856-62.
2008: Pugnale Paolo; Herrmann Eva; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Ferrari Carlo; Homburger Yonit; Zeuzem Stefan; Negro Francesco;
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
Journal of hepatology 2008;48(6):932-8.
2008: Klade Christoph S; Wedemeyer Heiner; Berg Thomas; Hinrichsen Holger; Cholewinska Grazyna; Zeuzem Stefan; Blum Hubert; Buschle Michael; Jelovcan Sandra; Buerger Vera; Tauber Erich; Frisch Juergen; Manns Michael P
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
Gastroenterology 2008;134(5):1385-95.
2008: Sung Joseph J Y; Lai Jak-Yiu; Zeuzem Stefan; Chow Wan Chen; Heathcote E Jenny; Perrillo Robert P; Brosgart Carol L; Woessner Mary A; Scott Susan A; Gray D Fraser; Gardner Stephen D
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.
Journal of hepatology 2008;48(5):728-35.
2008: Tang K H; Herrmann E; Pachiadakis I; Paulon E; Tatman N; Zeuzem S; Naoumov N V
Clinical trial: individualized treatment duration for hepatitis C virus genotype 1 with peginterferon-alpha 2a plus ribavirin.
Alimentary pharmacology & therapeutics 2008;27(9):810-9.
2008: Plotz Guido; Raedle Jochen; Spina Anna; Welsch Christoph; Stallmach Andreas; Zeuzem Stefan; Schmidt Carsten
Evaluation of the MLH1 I219V alteration in DNA mismatch repair activity and ulcerative colitis.
Inflammatory bowel diseases 2008;14(5):605-11.
2008: Friedrich-Rust Mireen; Ong Mei-Fang; Martens Swantje; Sarrazin Christoph; Bojunga Joerg; Zeuzem Stefan; Herrmann Eva
Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.
Gastroenterology 2008;134(4):960-74.
2008: Marcellin Patrick; Lau George K K; Zeuzem Stefan; Heathcote E Jenny; Pockros Paul J; Reddy K Rajender; Piratvisuth Teerha; Farci Patrizia; Chow Wan-Cheng; Jia Ji-Dong; Paik Woon; Wintfeld Neil; Pluck Nigel
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(4):477-85.
2008: Friedrich-Rust Mireen; Koch Constanze; Rentzsch Axel; Sarrazin Christoph; Schwarz Peter; Herrmann Eva; Lindinger Angelika; Sarrazin Ulrike; Poynard Thierry; Schäfers Hans-Joachim; Zeuzem Stefan; Abdul-Khaliq Hashim
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
The Journal of thoracic and cardiovascular surgery 2008;135(3):560-7.
2008: Friedrich-Rust Mireen; Herrmann Eva; Zeuzem Stefan; Sarrazin Christoph
Reply to Real-time elastography in the assessment of liver fibrosis.
AJR. American journal of roentgenology 2008;190(2):W164.
2008: Westin Johan; Ydreborg Magdalena; Islam Sara; Alsiö Asa; Dhillon Amar P; Pawlotsky Jean-Michel; Zeuzem Stefan; Schalm Solko W; Ferrari Carlo; Neumann Avidan U; Hellstrand Kristoffer; Lagging Martin;
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection.
Scandinavian journal of gastroenterology 2008;43(1):73-80.
2008: Snoeck Eric; Hadziyannis Stephanos J; Puoti Claudio; Swain Mark G; Berg Thomas; Marcellin Patrick; Zarski Jean-Pierre; Jorga Karin; Zeuzem Stefan
Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(1):61-71.
2008: Mihm Ulrike; Chan Henry Lik-Yuen; Zeuzem Stefan; Chim Angel Mei-Ling; Hui Alex Yui; Wong Vincent Wai-Sun; Sung Joseph Jao-Yiu; Herrmann Eva
Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis B.
Antiviral therapy 2008;13(8):1029-37.
2008: Kronenberger Bernd; Zeuzem Stefan
Future treatment options for HCV: double, triple, what is the optimal combination?
Best practice & research. Clinical gastroenterology 2008;22(6):1123-36.
2008: Zeuzem Stefan; Nelson David R; Marcellin Patrick
Dynamic evolution of therapy for chronic hepatitis C: how will novel agents be incorporated into the standard of care?
Antiviral therapy 2008;13(6):747-60.
2008: Gelderblom Huub C; Zeuzem Stefan; Weegink Christine J; Forestier Nicole; Mcnair Lindsay; Purdy Susan; Dijkgraaf Marcel G W; Jansen Peter L M; Reesink Henk W
Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a.
Scandinavian journal of gastroenterology 2008;43(9):1122-7.
2007: Lai Ching-Lung; Gane Edward; Liaw Yun-Fan; Hsu Chao-Wei; Thongsawat Satawat; Wang Yuming; Chen Yagang; Heathcote E Jenny; Rasenack Jens; Bzowej Natalie; Naoumov Nikolai V; Di Bisceglie Adrian M; Zeuzem Stefan; Moon Young Myoung; Goodman Zachary; Chao George; Constance Barbara Fielman; Brown Nathaniel A;
Telbivudine versus lamivudine in patients with chronic hepatitis B.
The New England journal of medicine 2007;357(25):2576-88.
2007: Subramanian G Mani; Fiscella Michele; Lamousé-Smith Araba; Zeuzem Stefan; McHutchison John G
Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C.
Nature biotechnology 2007;25(12):1411-9.
2007: Manns Michael P; Foster Graham R; Rockstroh Jürgen K; Zeuzem Stefan; Zoulim Fabien; Houghton Michael
The way forward in HCV treatment--finding the right path.
Nature reviews. Drug discovery 2007;6(12):991-1000.
2007: Brieger Angela; Plotz Guido; Zeuzem Stefan; Trojan Joerg
Thymosin beta 4 expression and nuclear transport are regulated by hMLH1.
Biochemical and biophysical research communications 2007;364(4):731-6.
2007: Veldt Bart J; Heathcote E Jenny; Wedemeyer Heiner; Reichen Juerg; Hofmann W Peter; Zeuzem Stefan; Manns Michael P; Hansen Bettina E; Schalm Solko W; Janssen Harry L A
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.
Annals of internal medicine 2007;147(10):677-84.
2007: Pilli Massimo; Zerbini Alessandro; Penna Amalia; Orlandini Alessandra; Lukasiewicz Esther; Pawlotsky Jean-Michel; Zeuzem Stefan; Schalm Solko W; von Wagner Michael; Germanidis Georgios; Lurie Yoav; Esteban Juan I; Haagmans Bart L; Hezode Christophe; Lagging Martin; Negro Francesco; Homburger Yonit; Neumann Avidan U; Ferrari Carlo; Missale Gabriele;
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
Gastroenterology 2007;133(4):1132-43.
2007: Dal Pero Francesca; Tang Kwok H; Gerotto Martina; Bortoletto Gladis; Paulon Emma; Herrmann Eva; Zeuzem Stefan; Alberti Alfredo; Naoumov Nikolai V
Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirin.
The Journal of infectious diseases 2007;196(7):998-1005.
2007: Forestier Nicole; Reesink Hendrik W; Weegink Christine J; McNair Lindsay; Kieffer Tara L; Chu Hui-May; Purdy Susan; Jansen Peter L M; Zeuzem Stefan
Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.
Hepatology (Baltimore, Md.) 2007;46(3):640-8.
2007: Hofmann Wolf Peter; Welsch Christoph; Takahashi Yoshitomo; Miyajima Hiroaki; Mihm Ulrike; Krick Christoph; Zeuzem Stefan; Sarrazin Christoph
Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
Scandinavian journal of gastroenterology 2007;42(9):1088-94.
2007: Kieffer Tara L; Sarrazin Christoph; Miller Janice S; Welker Martin W; Forestier Nicole; Reesink Hendrik W; Kwong Ann D; Zeuzem Stefan
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients.
Hepatology (Baltimore, Md.) 2007;46(3):631-9.
2007: Welsch Christoph; Albrecht Mario; Maydt Jochen; Herrmann Eva; Welker Martin Walter; Sarrazin Christoph; Scheidig Axel; Lengauer Thomas; Zeuzem Stefan
Structural and functional comparison of the non-structural protein 4B in flaviviridae.
Journal of molecular graphics & modelling 2007;26(2):546-57.
2007: Friedrich-Rust Mireen; Forestier Nicole; Sarrazin Christoph; Reesink Henk W; Herrmann Eva; Zeuzem Stefan
Ultrasound evaluation of perihepatic lymph nodes during antiviral therapy with the protease inhibitor telaprevir (VX-950) in patients with chronic hepatitis C infection.
Ultrasound in medicine & biology 2007;33(9):1362-7.
2007: Schmidt C; Giese T; Goebel R; Schilling M; Marth T; Ruether A; Schreiber S; Zeuzem S; Meuer S C; Stallmach A
Interleukin-18 is increased only in a minority of patients with active Crohn's disease.
International journal of colorectal disease 2007;22(9):1013-20.
2007: Keeffe Emmet B; Zeuzem Stefan; Koff Raymond S; Dieterich Douglas T; Esteban-Mur Rafael; Gane Edward J; Jacobson Ira M; Lim Seng G; Naoumov Nikolai; Marcellin Patrick; Piratvisuth Teerha; Zoulim Fabien
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(8):890-7.
2007: Kronenberger Bernd; Berg Thomas; Herrmann Eva; Hinrichsen Holger; Gerlach Tilman; Buggisch Peter; Spengler Ulrich; Goeser Tobias; Nasser Samer; Wursthorn Karsten; Pape Gerd R; Hopf Uwe; Zeuzem Stefan
Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.
European journal of gastroenterology & hepatology 2007;19(8):639-46.
2007: Shiffman Mitchell L; Suter Fredy; Bacon Bruce R; Nelson David; Harley Hugh; Solá Ricard; Shafran Stephen D; Barange Karl; Lin Amy; Soman Ash; Zeuzem Stefan;
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.
The New England journal of medicine 2007;357(2):124-34.
2007: Hofmann W P; Fernandez B; Herrmann E; Welsch C; Mihm U; Kronenberger B; Feldmann G; Spengler U; Zeuzem S; Sarrazin C
Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases.
Journal of viral hepatitis 2007;14(7):484-91.
2007: Haupenthal Jörg; Baehr Christina; Zeuzem Stefan; Piiper Albrecht
RNAse A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting polo-like kinase 1.
International journal of cancer. Journal international du cancer 2007;121(1):206-10.
2007: Friedrich-Rust M; Zeuzem S
[Transient elastography (FibroScan) for the non-invasive assessment of liver fibrosis: current status and perspectives]
Zeitschrift für Gastroenterologie 2007;45(5):387-94.
2007: Sarrazin Christoph; Kieffer Tara L; Bartels Doug; Hanzelka Brian; Müh Ute; Welker Martin; Wincheringer Dennis; Zhou Yi; Chu Hui-May; Lin Chao; Weegink Christine; Reesink Henk; Zeuzem Stefan; Kwong Ann D
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.
Gastroenterology 2007;132(5):1767-77.
2007: Westin Johan; Hellstrand Kristoffer; Alsiö Asa; Ydreborg Magdalena; Ferrari Carlo; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Zeuzem Stefan; Verhey-Hart Elke; Lagging Martin
Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2007;45(5):1333-4; author reply 1334.
2007: Welker M-W; Hofmann W-P; Welsch C; von Wagner M; Herrmann E; Lengauer T; Zeuzem S; Sarrazin C
Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients.
Journal of viral hepatitis 2007;14(5):338-49.
2007: Sarrazin Christoph; Rouzier Regine; Wagner Frank; Forestier Nicole; Larrey Dominique; Gupta Samir K; Hussain Musaddeq; Shah Amrik; Cutler David; Zhang Jenny; Zeuzem Stefan
SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders.
Gastroenterology 2007;132(4):1270-8.
2007: Friedrich-Rust Mireen; Zeuzem Stefan; Sarrazin Christoph
Current therapy for hepatitis C.
International journal of colorectal disease 2007;22(4):341-9.
2007: Hofmann Wolf Peter; Polta Andreas; Herrmann Eva; Mihm Ulrike; Kronenberger Bernd; Sonntag Tanja; Lohmann Volker; Schönberger Barbara; Zeuzem Stefan; Sarrazin Christoph
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.
Gastroenterology 2007;132(3):921-30.
2007: Schiff Eugene; Lai Ching-Lung; Hadziyannis Stephanos; Neuhaus Peter; Terrault Norah; Colombo Massimo; Tillmann Hans; Samuel Didier; Zeuzem Stefan; Villeneuve Jean-Pierre; Arterburn Sarah; Borroto-Esoda Katyna; Brosgart Carol; Chuck Steven;
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(3):349-60.
2007: Friedrich-Rust Mireen; Ong Mei-Fang; Herrmann Eva; Dries Volker; Samaras Panagiotis; Zeuzem Stefan; Sarrazin Christoph
Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis.
AJR. American journal of roentgenology 2007;188(3):758-64.
2007: Goyal Ankur; Hofmann Wolf P; Hermann Eva; Traver Stella; Hissar Syed S; Arora Naveen; Blum Hubert E; Zeuzem Stefan; Sarrazin Christoph; Sarin Shiv K
The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India.
Medical microbiology and immunology 2007;196(1):11-21.
2007: Gärtner Barbara C; Jung Wolfram; Welsch Christoph; Fischinger Johannes; Schubert Jörg; Zeuzem Stefan; Mueller-Lantzsch Nikolaus; Wend Ulrike C; Gerlich Wolfram H
Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;38(2):146-8.
2007: Westin J; Lagging M; Dhillon A P; Norkrans G; Romero A I; Pawlotsky J-M; Zeuzem S; Schalm S W; Verheij-Hart E; Negro F; Missale G; Neumann A U; Hellstrand K;
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.
Journal of viral hepatitis 2007;14(1):29-35.
2007: Schmidt Carsten; Giese Thomas; Hermann Eva; Zeuzem Stefan; Meuer Stefan C; Stallmach Andreas
Predictive value of mucosal TNF-alpha transcripts in steroid-refractory Crohn's disease patients receiving intensive immunosuppressive therapy.
Inflammatory bowel diseases 2007;13(1):65-70.
2007: Reddy K Rajender; Shiffman Mitchell L; Morgan Timothy R; Zeuzem Stefan; Hadziyannis Stephanos; Hamzeh Fayez M; Wright Teresa L; Fried Michael
Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(1):124-9.
2007: Lukasiewicz Esther; Hellstrand Kristoffer; Westin Johan; Ferrari Carlo; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Zeuzem Stefan; Veldt Bart J; Hansen Bettina E; Verhey-Hart Elke; Lagging Martin
Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
Hepatology (Baltimore, Md.) 2007;45(1):258-9.
2007: ter Borg Martijn J; Hansen Bettina E; Herrmann Eva; Zeuzem Stefan; Cakaloglu Yilmaz; Karayalcin Selim; Flisiak Robert; van' t Veen Annemarie; de Man Robert A; Schalm Solko W; Janssen Harry La; Haagmans Bart L;
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
Antiviral therapy 2007;12(8):1285-94.
2007: Kronenberger Bernd; Zeuzem Stefan; Sarrazin Christoph; Mihm Ulrike; von Wagner Michael; Hofmann W Peter; Piiper Albrecht; Herrmann Eva
Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C.
Antiviral therapy 2007;12(5):779-87.
2006: Lagging Martin; Romero Ana I; Westin Johan; Norkrans Gunnar; Dhillon Amar P; Pawlotsky Jean-Michel; Zeuzem Stefan; von Wagner Michael; Negro Francesco; Schalm Solko W; Haagmans Bart L; Ferrari Carlo; Missale Gabriele; Neumann Avidan U; Verheij-Hart Elke; Hellstrand Kristoffer;
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
Hepatology (Baltimore, Md.) 2006;44(6):1617-25.
2006: von Wagner M; Lee J-H; Kronenberger B; Friedl R; Sarrazin C; Teuber G; Herrmann E; Zeuzem S
Impaired health-related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels.
Journal of viral hepatitis 2006;13(12):828-34.
2006: Engel Matthias; Hindie Valerie; Lopez-Garcia Laura A; Stroba Adriana; Schaeffer Francis; Adrian Iris; Imig Jochen; Idrissova Leila; Nastainczyk Wolfgang; Zeuzem Stefan; Alzari Pedro M; Hartmann Rolf W; Piiper Albrecht; Biondi Ricardo M
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.
The EMBO journal 2006;25(23):5469-80.
2006: Reesink Hendrik W; Zeuzem Stefan; Weegink Christine J; Forestier Nicole; van Vliet Andre; van de Wetering de Rooij Jeroen; McNair Lindsay; Purdy Susan; Kauffman Robert; Alam John; Jansen Peter L M
Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study.
Gastroenterology 2006;131(4):997-1002.
2006: Zeuzem S; Alberti A; Rosenberg W; Marcellin P; Diago M; Negro F; Prati D; Puoti C; Roberts S K; Shiffman M L
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity.
Alimentary pharmacology & therapeutics 2006;24(8):1133-49.
2006: Romero Ana I; Lagging Martin; Westin Johan; Dhillon Amar P; Dustin Lynn B; Pawlotsky Jean-Michel; Neumann Avidan U; Ferrari Carlo; Missale Gabriele; Haagmans Bart L; Schalm Solko W; Zeuzem Stefan; Negro Francesco; Verheij-Hart Elke; Hellstrand Kristoffer;
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
The Journal of infectious diseases 2006;194(7):895-903.
2006: Orlent Hans; Hansen Bettina E; Willems Marc; Brouwer Johannes T; Huber Roman; Kullak-Ublick Gerd A; Gerken Guido; Zeuzem Stefan; Nevens Frederik; Tielemans Wanda C M; Zondervan Pieter E; Lagging Martin; Westin Johan; Schalm Solko W
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.
Journal of hepatology 2006;45(4):539-46.
2006: Zeuzem S
[Difficult-to-treat patients with chronic hepatitis C]
Praxis 2006;95(38):1459-64.
2006: Bojunga Jorg; Sarrazin Christoph; Hess Georg; Zeuzem Stefan
Elevated plasma levels of N-terminal pro-brain natriuretic peptide in patients with chronic hepatitis C during interferon-based antiviral therapy.
World journal of gastroenterology : WJG 2006;12(36):5875-7.
2006: ter Borg Martijn J; van Zonneveld Monika; Zeuzem Stefan; Senturk Hakan; Akarca Ulus S; Simon Christopher; Hansen Bettina E; Haagmans Bart L; de Man Robert A; Schalm Solko W; Janssen Harry L A;
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.
Hepatology (Baltimore, Md.) 2006;44(3):721-7.
2006: Plotz Guido; Zeuzem Stefan; Raedle Jochen
DNA mismatch repair and Lynch syndrome.
Journal of molecular histology 2006;37(5-7):271-83.
2006: Kronenberger Bernd; Herrmann Eva; Hofmann W Peter; Wedemeyer Heiner; Sester Martina; Mihm Ulrike; Ghaliai Temam; Zeuzem Stefan; Sarrazin Christoph
Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.
Journal of leukocyte biology 2006;80(2):298-308.
2006: Schmidt C; Giese T; Ludwig B; Menges M; Schilling M; Meuer S C; Zeuzem S; Stallmach A
Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity.
International journal of colorectal disease 2006;21(5):419-26.
2006: Hornberger J; Farci P; Prati D; Zeuzem S; Green J; Patel K K
The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase.
Journal of viral hepatitis 2006;13(6):377-86.
2006: Zeuzem S
[Individualised treatment of chronic hepatitis C]
Der Internist 2006;47 Suppl 1():S20, S22-5.
2006: Shiffman Mitchell L; Diago Moisés; Tran Albert; Pockros Paul; Reindollar Robert; Prati Daniele; Rodríguez-Torres Maribel; Lardelli Pilar; Blotner Steven; Zeuzem Stefan
Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(5):645-52.
2006: Strnad-Trojan Nicola; Linde Richard; Reichenbach Janine; Trojan Jörg; Zeuzem Stefan; Zielen Stefan
Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome.
European journal of pediatrics 2006;165(5):348-50.
2006: Berg Thomas; von Wagner Michael; Nasser Samer; Sarrazin Christoph; Heintges Tobias; Gerlach Tilman; Buggisch Peter; Goeser Tobias; Rasenack Jens; Pape Gerd R; Schmidt Wolfgang E; Kallinowski Birgit; Klinker Hartwig; Spengler Ulrich; Martus Peter; Alshuth Ulrich; Zeuzem Stefan
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.
Gastroenterology 2006;130(4):1086-97.
2006: Mihm U; Herrmann E; Sarrazin C; Zeuzem S
Review article: predicting response in hepatitis C virus therapy.
Alimentary pharmacology & therapeutics 2006;23(8):1043-54.
2006: Herrmann Eva; Zeuzem Stefan
The kinetics of hepatitis C virus.
European journal of gastroenterology & hepatology 2006;18(4):339-42.
2006: Prati Daniele; Shiffman Mitchell L; Diago Moisés; Gane Edward; Rajender Reddy K; Pockros Paul; Farci Patrizia; O'Brien Christopher B; Lardelli Pilar; Blotner Steven; Zeuzem Stefan
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C.
Journal of hepatology 2006;44(4):679-85.
2006: Sarrazin Christoph; Gärtner Barbara C; Sizmann Dorothea; Babiel Rainer; Mihm Ulrike; Hofmann Wolf Peter; von Wagner Michael; Zeuzem Stefan
Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.
Journal of clinical microbiology 2006;44(3):729-37.
2006: Arora Sanjeev; O'Brien Christopher; Zeuzem Stefan; Shiffman Mitchell L; Diago Moises; Tran Albert; Pockros Paul J; Reindollar Robert W; Gane Edward; Patel Kavita; Wintfeld Neil; Green Jesse
Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life.
Journal of gastroenterology and hepatology 2006;21(2):406-12.
2006: Wiegand Johannes; Buggisch Peter; Boecher Wulf; Zeuzem Stefan; Gelbmann Cornelia M; Berg Thomas; Kauffmann Wolfgang; Kallinowski Birgit; Cornberg Markus; Jaeckel Elmar; Wedemeyer Heiner; Manns Michael P;
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.
Hepatology (Baltimore, Md.) 2006;43(2):250-6.
2006: Plotz Guido; Piiper Albrecht; Wormek Marc; Zeuzem Stefan; Raedle Jochen
Analysis of the human MutLalpha.MutSalpha complex.
Biochemical and biophysical research communications 2006;340(3):852-9.
2006: Haupenthal Jörg; Baehr Christina; Kiermayer Simone; Zeuzem Stefan; Piiper Albrecht
Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum.
Biochemical pharmacology 2006;71(5):702-10.
2006: Hofmann W P; Bock H; Weber C; Tacke W; Pfaff R; Kihn R; Moog G; Kellner H U; Schöfer M; Frick B; Berg P; Rambow A; Friedrich-Rust M; Herrmann E; Sarrazin C; Zeuzem S
[Effectiveness of antiviral therapy in patients with chronic hepatitis C treated by private practice gastroenterologists]
Zeitschrift für Gastroenterologie 2006;44(1):25-31.
2006: Zeuzem Stefan; Buti Maria; Ferenci Peter; Sperl Jan; Horsmans Yves; Cianciara Janusz; Ibranyi Endre; Weiland Ola; Noviello Stephanie; Brass Clifford; Albrecht Janice
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.
Journal of hepatology 2006;44(1):97-103.
2006: Plotz Guido; Welsch Christoph; Giron-Monzon Luis; Friedhoff Peter; Albrecht Mario; Piiper Albrecht; Biondi Ricardo M; Lengauer Thomas; Zeuzem Stefan; Raedle Jochen
Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair.
Nucleic acids research 2006;34(22):6574-86.
2006: Mihm Ulrike; Grigorian Natalia; Welsch Christoph; Herrmann Eva; Kronenberger Bernd; Teuber Gerlinde; von Wagner Michael; Hofmann Wolf-Peter; Albrecht Mario; Lengauer Thomas; Zeuzem Stefan; Sarrazin Christoph
Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
Antiviral therapy 2006;11(4):507-19.
2006: Herrmann Eva; Zeuzem Stefan; Sarrazin Christoph; Hinrichsen Holger; Benhamou Yves; Manns Michael P; Reiser Markus; Reesink Henk; Calleja José L; Forns Xavier; Steinmann Gerhard G; Nehmiz Gerhard
Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.
Antiviral therapy 2006;11(3):371-6.
2006: Zeuzem Stefan
The American Association For the Study of Liver Diseases: new perspectives in the treatment of hepatitis C.
Antiviral therapy 2006;11(2):267-71.
2005: Friedrich-Rust M; Forestier N; Zeuzem S
[Perspectives in hepatology in the next 2-3 years: what will be clinically relevant? Viral hepatitis]
Deutsche medizinische Wochenschrift (1946) 2005;130 Suppl 5():S229-30.
2005: Forestier N; Zeuzem S
[Treatment of hepatitis C--update 2005]
Deutsche medizinische Wochenschrift (1946) 2005;130 Suppl 5():S215-6.
2005: Kiermayer Simone; Biondi Ricardo M; Imig Jochen; Plotz Guido; Haupenthal Jörg; Zeuzem Stefan; Piiper Albrecht
Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells.
Molecular biology of the cell 2005;16(12):5639-48.
2005: Sarrazin Christoph; Mihm Ulrike; Herrmann Eva; Welsch Christoph; Albrecht Mario; Sarrazin Ulrike; Traver Stella; Lengauer Thomas; Zeuzem Stefan
Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
The Journal of infectious diseases 2005;192(10):1710-9.
2005: Tang Kwok H; Herrmann Eva; Cooksley Helen; Tatman Nick; Chokshi Shilpa; Williams Roger; Zeuzem Stefan; Naoumov Nikolai V
Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy.
Journal of hepatology 2005;43(5):776-82.
2005: Perelson Alan S; Herrmann Eva; Micol Florence; Zeuzem Stefan
New kinetic models for the hepatitis C virus.
Hepatology (Baltimore, Md.) 2005;42(4):749-54.
2005: Bojunga Jörg; Welsch Christoph; Antes Iris; Albrecht Mario; Lengauer Thomas; Zeuzem Stefan
Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency.
Human genetics 2005;117(6):558-64.
2005: Sarrazin Christoph; Berg Thomas; Weich Viola; Mueller Tobias; Frey Ulrich H; Zeuzem Stefan; Gerken Guido; Roggendorf Michael; Siffert Winfried
GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection.
Journal of hepatology 2005;43(3):388-93.
2005: Lubomierski Nikolaus; Plotz Guido; Wormek Marc; Engels Knut; Kriener Susanne; Trojan Jorg; Jungling Bernd; Zeuzem Stefan; Raedle Jochen
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
Cancer 2005;104(5):952-61.
2005: von Wagner Michael; Huber Miriam; Berg Thomas; Hinrichsen Holger; Rasenack Jens; Heintges Tobias; Bergk Alexandra; Bernsmeier Christine; Häussinger Dieter; Herrmann Eva; Zeuzem Stefan
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.
Gastroenterology 2005;129(2):522-7.
2005: Zeuzem Stefan; Pawlotsky Jean-Michel; Lukasiewicz Esther; von Wagner Michael; Goulis Ioannis; Lurie Yoav; Gianfranco Elia; Vrolijk Jan-Maarten; Esteban Juan I; Hezode Christophe; Lagging Martin; Negro Francesco; Soulier Alexandre; Verheij-Hart Elke; Hansen Bettina; Tal Ronen; Ferrari Carlo; Schalm Solko W; Neumann Avidan U;
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.
Journal of hepatology 2005;43(2):250-7.
2005: Mihm Ulrike; Gärtner Barbara Christine; Faust Dominik; Hofmann Wolf Peter; Sarrazin Christoph; Zeuzem Stefan; Herrmann Eva
Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir-lamivudine combination therapy.
Journal of hepatology 2005;43(2):217-24.
2005: Kalt A; Wagner A; Zeuzem S; Tilgen W; Reichrath J
[Generalized hyperpigmentation and malignant acanthosis nigricans. A case of a patient with hereditary hemochromatosis and gastric cancer]
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2005;56(6):581-5.
2005: Zeuzem S
[Treatment of hepatitis C virus infection]
Praxis 2005;94(18):721-6.
2005: Alberti Alfredo; Clumeck Nathan; Collins Simon; Gerlich Wolfram; Lundgren Jens; Palù Giorgio; Reiss Peter; Thiebaut Rodolphe; Weiland Ola; Yazdanpanah Yazdan; Zeuzem Stefan;
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
Journal of hepatology 2005;42(5):615-24.
2005: van Zonneveld M; Flink H J; Verhey E; Senturk H; Zeuzem S; Akarca U S; Cakaloglu Y; Simon C; So T M K; Gerken G; de Man R A; Hansen B E; Schalm S W; Janssen H L A;
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
Alimentary pharmacology & therapeutics 2005;21(9):1163-71.
2005: Kronenberger B; Wagner M; Herrmann E; Mihm U; Piiper A; Sarrazin C; Zeuzem S
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
Journal of viral hepatitis 2005;12(3):307-14.
2005: Brieger A; Plotz G; Raedle J; Weber N; Baum W; Caspary W F; Zeuzem S; Trojan J
Characterization of the nuclear import of human MutLalpha.
Molecular carcinogenesis 2005;43(1):51-8.
2005: Hofmann Wolf Peter; Dries Volker; Herrmann Eva; Gärtner Barbara; Zeuzem Stefan; Sarrazin Christoph
Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;32(4):289-93.
2005: Mihm Ulrike; Hofmann Wolf-Peter; Kronenberger Bernd; Wagner Michael von; Zeuzem Stefan; Sarrazin Christoph
Highly sensitive hepatitis C virus RNA detection assays for decision of treatment (dis)continuation in patients with chronic hepatitis C.
Journal of hepatology 2005;42(4):605-6.
2005: Jüngling B; Kindermann I; Moser C; Püschel W; Ecker K W; Schäfers H J; Böhm M; Zeuzem S; Giese T; Stallmach A
Development of ulcerative colitis after heart transplantation during immunosuppressive therapy.
Zeitschrift für Gastroenterologie 2005;43(2):195-9.
2005: Hofmann Wolf Peter; Zeuzem Stefan; Sarrazin Christoph
Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;32(2):86-91.
2005: Braden B; Faust D; Sarrazin U; Zeuzem S; Dietrich C F; Caspary W F; Sarrazin C
13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.
Alimentary pharmacology & therapeutics 2005;21(2):179-85.
2005: Schmidt Carsten; Giese Thomas; Ludwig Bianca; Mueller-Molaian Ina; Marth Thomas; Zeuzem Stefan; Meuer Stefan C; Stallmach Andreas
Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.
Inflammatory bowel diseases 2005;11(1):16-23.
2005: Janssen Harry L A; van Zonneveld Monika; Senturk Hakan; Zeuzem Stefan; Akarca Ulus S; Cakaloglu Yilmaz; Simon Christopher; So Thomas M K; Gerken Guido; de Man Robert A; Niesters Hubert G M; Zondervan Pieter; Hansen Bettina; Schalm Solko W;
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.
Lancet 2005;365(9454):123-9.
2005: Zeuzem Stefan
News in hepatitis C: Report from the 39th annual meeting of the European Association for the Study of the Liver.
Antiviral therapy 2005;10(1):179-83.
2004: Bojunga J; Nowak D; Mitrou P S; Hoelzer D; Zeuzem S; Chow K U
Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats.
Diabetologia 2004;47(12):2072-80.
2004: Zeuzem Stefan; Diago Moisés; Gane Edward; Reddy K Rajender; Pockros Paul; Prati Daniele; Shiffman Mitchell; Farci Patrizia; Gitlin Norman; O'Brien Christopher B; Lamour François; Lardelli Pilar;
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.
Gastroenterology 2004;127(6):1724-32.
2004: Kronenberger Bernd; Herrmann Eva; Micol Florence; von Wagner Michael; Zeuzem Stefan
Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels.
Hepatology (Baltimore, Md.) 2004;40(6):1442-9.
2004: Bojunga Jörg; Zeuzem Stefan
Molecular detection of thyroid cancer: an update.
Clinical endocrinology 2004;61(5):523-30.
2004: Hirche Tim O; Russler Jan; Braden Barbara; Schuessler Gudrun; Zeuzem Stefan; Wehrmann Till; Seifert Hans; Dietrich Christoph F
Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease.
International journal of colorectal disease 2004;19(6):586-94.
2004: Trojan Joerg; Brieger Angela; Raedle Jochen; Weber Nicole; Kriener Susanne; Kronenberger Bernd; Caspary Wolfgang F; Zeuzem Stefan
BAX and caspase-5 frameshift mutations and spontaneous apoptosis in colorectal cancer with microsatellite instability.
International journal of colorectal disease 2004;19(6):538-44.
2004: Zeuzem S
[Treatment of hepatitis B and C -- current standards]
Deutsche medizinische Wochenschrift (1946) 2004;129 Suppl 2():S57-9.
2004: Zeuzem Stefan
Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?
Journal of hepatology 2004;41(3):488-90.
2004: Zeuzem S
[Standard treatment of acute and chronic hepatitis C]
Zeitschrift für Gastroenterologie 2004;42(8):714-9.
2004: Hofmann Wolf Peter; Herrmann Eva; Kronenberger Bernd; Merkwirth Christian; Welsch Christoph; Lengauer Thomas; Zeuzem Stefan; Sarrazin Christoph
Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes.
Blood 2004;104(4):1228-9.
2004: Kronenberger B; Sarrazin C; Hofmann W P; von Wagner M; Herrmann E; Welsch C; Elez R; Rüster B; Piiper A; Zeuzem S
Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
Journal of viral hepatitis 2004;11(4):310-8.
2004: Zeuzem Stefan; Hultcrantz Rolf; Bourliere Marc; Goeser Tobias; Marcellin Patrick; Sanchez-Tapias Jose; Sarrazin Christoph; Harvey Joann; Brass Clifford; Albrecht Janice
Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3.
Journal of hepatology 2004;40(6):993-9.
2004: Zeuzem S
[Chronic hepatitis C: new perspectives in therapy]
Zeitschrift für Gastroenterologie 2004;42(5):363-4.
2004: Berg Thomas; Sarrazin Christoph; Hinrichsen Holger; Buggisch Peter; Gerlach Tilman; Zachoval Reinhart; Zeuzem Stefan
Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?
Hepatology (Baltimore, Md.) 2004;39(5):1456-7; author reply 1457-8.
2004: Mihm Ulrike; Herrmann Eva; Sarrazin Ulrike; von Wagner Michael; Kronenberger Bernd; Zeuzem Stefan; Sarrazin Christoph
Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C.
Journal of hepatology 2004;40(5):845-52.
2004: Bojunga Jörg; Dresar-Mayert Birgit; Usadel Klaus-Henning; Kusterer Klaus; Zeuzem Stefan
Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats.
Biochemical and biophysical research communications 2004;316(3):771-80.
2004: Zeuzem Stefan
Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?
Annals of internal medicine 2004;140(5):370-81.
2004: Hadziyannis Stephanos J; Sette Hoel; Morgan Timothy R; Balan Vijayan; Diago Moises; Marcellin Patrick; Ramadori Giuliano; Bodenheimer Henry; Bernstein David; Rizzetto Mario; Zeuzem Stefan; Pockros Paul J; Lin Amy; Ackrill Andrew M;
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
Annals of internal medicine 2004;140(5):346-55.
2004: Stallmach A; Marth T; Weiss B; Wittig B M; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
Gut 2004;53(3):339-45.
2004: Sarrazin U; Brodt R; Sarrazin C; Zeuzem S
[Postexposure prevention after occupational exposure to HBV, HCV and HIV]
Der Unfallchirurg 2004;107(2):129-142.
2004: Sarrazin U; Brodt R; Sarrazin C; Zeuzem S
[Post-exposure prevention after occupational exposure to HBV, HCV and HIV]
Der Orthopäde 2004;33(2):231-44.
2004: Sarrazin U; Brodt R; Sarrazin C; Zeuzem S
[Postexposure prophylaxis after occupational exposure to HBV, HCV and HIV]
Der Radiologe 2004;44(2):181-94.
2004: Cammà Calogero; Di Bona Danilo; Schepis Filippo; Heathcote E Jenny; Zeuzem Stefan; Pockros Paul J; Marcellin Patrick; Balart Luis; Alberti Alfredo; Craxì Antonio
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.
Hepatology (Baltimore, Md.) 2004;39(2):333-42.
2004: Heathcote Jenny; Zeuzem Stefan
Pegylated interferon monotherapy for chronic hepatitis C.
Seminars in liver disease 2004;24 Suppl 2():39-45.
2004: Zeuzem Stefan
Overview of commercial HBV assays systems.
Methods in molecular medicine 2004;95():3-13.
2003: Schiff Eugene R; Lai Ching-Lung; Hadziyannis Stefanos; Neuhaus Peter; Terrault Norah; Colombo Massimo; Tillmann Hans L; Samuel Didier; Zeuzem Stefan; Lilly Leslie; Rendina Maria; Villeneuve Jean-Pierre; Lama Nicole; James Craig; Wulfsohn Michael S; Namini Hamid; Westland Christopher; Xiong Shelly; Choy Gavin S; Van Doren Sally; Fry John; Brosgart Carol L;
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.
Hepatology (Baltimore, Md.) 2003;38(6):1419-27.
2003: Sarrazin U; Brodt R; Sarrazin C; Zeuzem S
[Postexposure prevention after occupational exposure to HBV, HCV and HIV]
Der Urologe. Ausg. A 2003;42(11):1497-1510; quiz 1511-2.
2003: von Wagner M; Lee J-H; Rüster B; Kronenberger B; Sarrazin C; Roth W K; Zeuzem S
Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.
Journal of viral hepatitis 2003;10(6):413-22.
2003: Kerber A; Sarrazin C; Allers C; Markus B; Engels K; Caspary W; Zeuzem S
[44-year-old patient with fulminant liver failure]
Der Internist 2003;44(10):1301-7.
2003: Teuber Gerlinde; Pascu M; Berg T; Lafrenz M; Pausch J; Kullmann F; Ramadori G; Arnold R; Weidenbach H; Musch E; Junge U; Wiedmann K H; Herrmann E; Zankel M; Zeuzem S
Randomized, controlled trial with IFN-alpha combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C.
Journal of hepatology 2003;39(4):606-13.
2003: Poynard Thierry; Ratziu Vlad; McHutchison John; Manns Michael; Goodman Zachary; Zeuzem Stefan; Younossi Zobair; Albrecht Janice
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.
Hepatology (Baltimore, Md.) 2003;38(1):75-85.
2003: Zeuzem Stefan; Heathcote E Jenny; Shiffman Mitchell L; Wright Teresa L; Bain Vincent G; Sherman Morris; Feinman S Victor; Fried Michael W; Rasenack Jens; Sarrazin Christoph; Jensen Donald M; Lin Amy; Hoffman Joseph H; Sedarati Farhad
Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C.
Journal of hepatology 2003;39(1):106-11.
2003: Plotz Guido; Raedle Jochen; Brieger Angela; Trojan Jörg; Zeuzem Stefan
N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha.
Nucleic acids research 2003;31(12):3217-26.
2003: Stallmach A; Wittig B M; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz W A
Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
Experimental and molecular pathology 2003;74(3):262-6.
2003: Faust Dominik; Rabenau Holger F; Allwinn Regina; Caspary Wolfgang F; Zeuzem Stefan
Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation.
Clinical transplantation 2003;17(3):254-8.
2003: Berg Thomas; Kronenberger Bernd; Hinrichsen Holger; Gerlach Tilman; Buggisch Peter; Herrmann Eva; Spengler Ulrich; Goeser Tobias; Nasser Samer; Wursthorn Karsten; Pape Gerd R; Hopf Uwe; Zeuzem Stefan
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial.
Hepatology (Baltimore, Md.) 2003;37(6):1359-67.
2003: Herrmann Eva; Lee Jung-Hun; Marinos George; Modi Marlene; Zeuzem Stefan
Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon.
Hepatology (Baltimore, Md.) 2003;37(6):1351-8.
2003: Hofmann W P; Zeuzem S
[Is liver fibrosis a reversible event? Effect of pegylated interferon and ribavirin in patients with chronic hepatitis C]
Zeitschrift für Gastroenterologie 2003;41(3):271-4.
2003: Faust D; Fellbaum C; Zeuzem S; Dietrich C F
Nodular regenerative hyperplasia of the liver: a rare differential diagnosis of cholestasis with response to ursodeoxycholic acid.
Zeitschrift für Gastroenterologie 2003;41(3):255-8.
2003: Mihm U; Sarrazin C; Herrmann E; Teuber G; von Wagner M; Kronenberger B; Zeuzem S
Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B.
Zeitschrift für Gastroenterologie 2003;41(3):249-54.
2003: Hofmann Wolf Peter; Sarrazin Christoph; Kronenberger Bernd; Schönberger Barbara; Bruch Katharina; Zeuzem Stefan
Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
The Journal of infectious diseases 2003;187(6):982-7.
2003: Berg Thomas; Sarrazin Christoph; Herrmann Eva; Hinrichsen Holger; Gerlach Tilman; Zachoval Reinhart; Wiedenmann Bertram; Hopf Uwe; Zeuzem Stefan
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy.
Hepatology (Baltimore, Md.) 2003;37(3):600-9.
2003: Zeuzem S
[Combination therapy for chronic viral hepatitis C]
Deutsche medizinische Wochenschrift (1946) 2003;128(8):370-4.
2003: Piiper Albrecht; Lutz Manfred P; Cramer Henning; Elez Robert; Kronenberger Bernd; Dikic Ivan; Müller-Esterl Werner; Zeuzem Stefan
Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptor.
Biochemical and biophysical research communications 2003;301(4):848-54.
2003: Piiper Albrecht; Elez Robert; You Se-Jong; Kronenberger Bernd; Loitsch Stefan; Roche Serge; Zeuzem Stefan
Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
The Journal of biological chemistry 2003;278(9):7065-72.
2003: Elez Robert; Piiper Albrecht; Kronenberger Bernd; Kock Martin; Brendel Martin; Hermann Eva; Pliquett Uwe; Neumann Eberhardt; Zeuzem Stefan
Tumor regression by combination antisense therapy against Plk1 and Bcl-2.
Oncogene 2003;22(1):69-80.
2003: Zeuzem Stefan; Welsch Christoph; Herrmann Eva
Pharmacokinetics of peginterferons.
Seminars in liver disease 2003;23 Suppl 1():23-8.
2003: Rasenack Jens; Zeuzem Stefan; Feinman S Victor; Heathcote E Jenny; Manns Michael; Yoshida Eric M; Swain Mark G; Gane Edward; Diago Moises; Revicki Dennis A; Lin Amy; Wintfeld Neil; Green Jesse
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C.
PharmacoEconomics 2003;21(5):341-9.
2002: Cornberg Markus; Hinrichsen Holger; Teuber Gerlinde; Berg Thomas; Naumann Uta; Falkenberg Christian; Zeuzem Stefan; Manns Michael P
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.
Journal of hepatology 2002;37(6):843-7.
2002: Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
Gut 2002;51(5):677-84.
2002: Sarrazin Christoph; Herrmann Eva; Bruch Katharina; Zeuzem Stefan
Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses.
Journal of virology 2002;76(21):11079-90.
2002: Piiper Albrecht; Dikic Ivan; Lutz Manfred P; Leser Jürgen; Kronenberger Bernd; Elez Robert; Cramer Henning; Müller-Esterl Werner; Zeuzem Stefan
Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells.
The Journal of biological chemistry 2002;277(46):43623-30.
2002: Jung Maria-Christina; Grüner Norbert; Zachoval Reinhart; Schraut Winfried; Gerlach Tilman; Diepolder Helmut; Schirren Carl-Albrecht; Page Mark; Bailey John; Birtles Emma; Whitehead Eve; Trojan Jörg; Zeuzem Stefan; Pape Gerd R
Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers.
Vaccine 2002;20(29-30):3598-612.
2002: Lee Samuel S; Heathcote E Jenny; Reddy K Rajender; Zeuzem Stefan; Fried Michael W; Wright Teresa L; Pockros Paul J; Häussinger Dieter; Smith Coleman I; Lin Amy; Pappas Stephen C
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).
Journal of hepatology 2002;37(4):500-6.
2002: Zeuzem Stefan; Herrmann Eva
First-phase parameters in hepatitis C viral kinetics.
Journal of viral hepatitis 2002;9(5):332-3.
2002: Zeuzem S
[Chronic hepatitis C virus infection: always treat!--Pro]
Deutsche medizinische Wochenschrift (1946) 2002;127(36):1840.
2002: Raedle J; Schaffner M; Esser N; Sahm S; Trojan J; Kriener S; Brieger A; Nier H; Bockhorn H; Berg P L; Frick B; Schäfer D; Zeuzem S
Frequency of the Amsterdam criteria in a regional German cohort of patients with colorectal cancer.
Zeitschrift für Gastroenterologie 2002;40(8):561-8.
2002: Teuber G; Rossol S; Lee J-H; Dietrich C F; Zeuzem S
TH1/TH2 serum cytokine profiles and soluble TNF-receptor response in patients with chronic hepatitis C during recombinant human interleukin-12 (rHuIL-12) treatment.
Zeitschrift für Gastroenterologie 2002;40(7):487-95.
2002: Zeuzem Stefan
Favourable and disappointing lessons from viral kinetics.
Journal of hepatology 2002;37(1):151-3.
2002: Zeuzem Stefan; Herrmann Eva
Dynamics of hepatitis C virus infection.
Annals of hepatology : official journal of the Mexican Association of Hepatology 2002;1(2):56-63.
2002: Wolters Lonieke M M; Hansen Bettina E; Niesters Hubert G M; Zeuzem Stefan; Schalm Solko W; de Man Robert A
Viral dynamics in chronic hepatitis B patients during lamivudine therapy.
Liver 2002;22(2):121-6.
2002: Trojan Joerg; Kronenberger Bernd; von Wagner Michael; Zeuzem Stefan
Lack of birth defects after paternal exposure to lamivudine.
Journal of hepatology 2002;36(4):571.
2002: Zeuzem S
[Pegylated interferon plus ribavirin in chronic hepatitis C. More than half of patients show a lasting response]
MMW Fortschritte der Medizin 2002;144(8):30-4.
2002: Trojan Joerg; Raedle Jochen; Herrmann Guenter; Brieger Angela; Zeuzem Stefan
Detection of microsatellite instability from archival, hematoxylin-eosin-stained colorectal cancer specimen.
Archives of pathology & laboratory medicine 2002;126(2):202-4.
2002: Plotz Guido; Raedle Jochen; Brieger Angela; Trojan Jörg; Zeuzem Stefan
hMutSalpha forms an ATP-dependent complex with hMutLalpha and hMutLbeta on DNA.
Nucleic acids research 2002;30(3):711-8.
2002: Trojan Joerg; Zeuzem Stefan; Randolph Ann; Hemmerle Christine; Brieger Angela; Raedle Jochen; Plotz Guido; Jiricny Josef; Marra Giancarlo
Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system.
Gastroenterology 2002;122(1):211-9.
2001: Trojan J; Plotz G; Brieger A; Raedle J; Meltzer S J; Wolter M; Zeuzem S
Activation of a cryptic splice site of PTEN and loss of heterozygosity in benign skin lesions in Cowden disease.
The Journal of investigative dermatology 2001;117(6):1650-3.
2001: Zeuzem S; Heathcote J E; Martin N; Nieforth K; Modi M
Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy.
Expert opinion on investigational drugs 2001;10(12):2201-13.
2001: Hofmann W P; Dietrich C F; Holtmeier W; Caspary W F; Zeuzem S
[Hypertransaminasaemia and impaired liver function in a patient with oligosymptomatic celiac disease]
Zeitschrift für Gastroenterologie 2001;39(12):1027-32.
2001: Zeuzem S
The kinetics of hepatitis C virus infection.
Clinics in liver disease 2001;5(4):917-30.
2001: Hammerstingl R M; Schwarz W V; Schmitt E; Faust D; Dietrich C; Zeuzem S; Vogl T J
[Diagnostic imaging in liver cirrhosis]
Der Radiologe 2001;41(10):852-67.
2001: Huber M; Schwarz W; Vogl T; Zeuzem S
[Clinical aspects of liver cirrhoses and its complications and diagnostic problems]
Der Radiologe 2001;41(10):840-51.
2001: Raedle J; Friedl W; Engels H; Koenig R; Trojan J; Zeuzem S
A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardation.
The American journal of gastroenterology 2001;96(10):3016-20.
2001: Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
Annals of internal medicine 2001;135(8 Pt 1):566-76.
2001: Sarrazin C; Bruckner M; Herrmann E; Rüster B; Bruch K; Roth W K; Zeuzem S
Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy.
Virology 2001;289(1):150-63.
2001: Piiper A; Leser J; Lutz M P; Beil M; Zeuzem S
Subcellular distribution and function of Rab3A-D in pancreatic acinar AR42J cells.
Biochemical and biophysical research communications 2001;287(3):746-51.
2001: Sarrazin C; Hendricks D A; Sedarati F; Zeuzem S
Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a.
Journal of clinical microbiology 2001;39(8):2850-5.
2001: Teuber G; Berg T; Naumann U; Raedle J; Brinkmann S; Hopf U; Zeuzem S
Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C.
Journal of viral hepatitis 2001;8(4):276-83.
2001: Kronenberger B; Rüster B; Elez R; Weber S; Piiper A; Lee J H; Roth W K; Zeuzem S
Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2001;33(6):1518-26.
2001: Zeuzem S
What is (cost) effective in patients with chronic hepatitis C virus infection?
European journal of gastroenterology & hepatology 2001;13(5):473-6.
2001: Zeuzem S; Herrmann E; Lee J H; Fricke J; Neumann A U; Modi M; Colucci G; Roth W K
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a.
Gastroenterology 2001;120(6):1438-47.
2001: Teuber G; Löhr H F; Kallinowski B; Berg T; Müller R; Zeuzem S
[Retrospective cohort study of lamivudine therapy in patients with chronic hepatitis B]
Deutsche medizinische Wochenschrift (1946) 2001;126(5):97-102.
2001: Rüster B; Zeuzem S; Krump-Konvalinkova V; Berg T; Jonas S; Severin K; Roth W K
Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue.
Journal of medical virology 2001;63(2):128-34.
2000: Berg T; Hoffmann R M; Teuber G; Leifeld L; Lafrenz M; Baumgarten R; Spengler U; Zeuzem S; Pape G R; Hopf U
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.
Liver 2000;20(6):427-36.
2000: Zeuzem S; Feinman S V; Rasenack J; Heathcote E J; Lai M Y; Gane E; O'Grady J; Reichen J; Diago M; Lin A; Hoffman J; Brunda M J
Peginterferon alfa-2a in patients with chronic hepatitis C.
The New England journal of medicine 2000;343(23):1666-72.
2000: Kronenberger B; Rüster B; Lee J H; Sarrazin C; Roth W K; Herrmann G; Zeuzem S
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels.
Journal of hepatology 2000;33(4):640-7.
2000: Zeuzem S; Teuber G; Naumann U; Berg T; Raedle J; Hartmann S; Hopf U
Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C.
Hepatology (Baltimore, Md.) 2000;32(4 Pt 1):835-41.
2000: Sarrazin C; Teuber G; Kokka R; Rabenau H; Zeuzem S
Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays.
Hepatology (Baltimore, Md.) 2000;32(4 Pt 1):818-23.
2000: Sarrazin C; Rüster B; Lee J H; Kronenberger B; Roth W K; Zeuzem S
Prospective follow-up of patients with GBV-C/HGV infection: specific mutational patterns, clinical outcome, and genetic diversity.
Journal of medical virology 2000;62(2):191-8.
2000: Zeuzem S
Treatment of chronic hepatitis C virus infection in patients with cirrhosis.
Journal of viral hepatitis 2000;7(5):327-34.
2000: Piiper A; Gebhardt R; Kronenberger B; Giannini C D; Elez R; Zeuzem S
Pertussis toxin inhibits cholecystokinin- and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1.
Molecular pharmacology 2000;58(3):608-13.
2000: Trojan J; Brieger A; Raedle J; Esteller M; Zeuzem S
5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer.
Gut 2000;47(2):272-6.
2000: Trojan J; Raedle J; Zeuzem S
[Germline mutations of the MSH6 gene in patients with an atypical hereditary nonpolyposis colorectal carcinoma (HNPCC)]
Zeitschrift für Gastroenterologie 2000;38(7):607-9.
2000: Sarrazin C; Kornetzky I; Rüster B; Lee J H; Kronenberger B; Bruch K; Roth W K; Zeuzem S
Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response.
Hepatology (Baltimore, Md.) 2000;31(6):1360-70.
2000: Zeuzem S
Gut-liver axis.
International journal of colorectal disease 2000;15(2):59-82.
2000: Trojan J; Schwarz W; Zeuzem S; Dietrich C F
Cystic adrenal lymphangioma: incidental diagnosis on abdominal sonography.
AJR. American journal of roentgenology 2000;174(4):1164-5.
2000: Elez R; Piiper A; Giannini C D; Brendel M; Zeuzem S
Polo-like kinase1, a new target for antisense tumor therapy.
Biochemical and biophysical research communications 2000;269(2):352-6.
2000: Dietrich C F; Stryjek-Kaminska D; Teuber G; Lee J H; Caspary W F; Zeuzem S
Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C infection.
AJR. American journal of roentgenology 2000;174(3):699-704.
2000: Lee J H; Teuber G; von Wagner M; Roth W K; Zeuzem S
Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus.
Journal of medical virology 2000;60(3):264-8.
2000: Dietrich C F; Viel K; Braden B; Caspary W F; Zeuzem S
[Mediastinal lymphadenopathy: an extrahepatic manifestation of chronic hepatitis C?]
Zeitschrift für Gastroenterologie 2000;38(2):143-52.
2000: Carreño V; Zeuzem S; Hopf U; Marcellin P; Cooksley W G; Fevery J; Diago M; Reddy R; Peters M; Rittweger K; Rakhit A; Pardo M
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B.
Journal of hepatology 2000;32(2):317-24.
2000: Sarrazin C; Berg T; Lee J H; Rüster B; Kronenberger B; Roth W K; Zeuzem S
Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response.
The Journal of infectious diseases 2000;181(2):432-41.
2000: Konrad T; Zeuzem S; Vicini P; Toffolo G; Briem D; Lormann J; Herrmann G; Berger A; Kusterer K; Teuber G; Cobelli C; Usadel K H
Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha.
European journal of clinical investigation 2000;30(2):111-21.
2000: Zeuzem S
Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy.
Forum (Genoa, Italy) 2000;10(1):32-42.
2000: Konrad T; Zeuzem S; Toffolo G; Vicini P; Teuber G; Briem D; Lormann J; Lenz T; Herrmann G; Berger A; Cobelli C; Usadel K
Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection.
Digestion 2000;62(1):52-9.
2000: Teuber G; Berg T; Hoffmann R M; Leifeld L; Lafrenz M; Spengler U; Pape G R; Hopf U; Zeuzem S
Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C.
Digestion 2000;61(2):90-7.
1999: Trojan J; Schroeder O; Raedle J; Baum R P; Herrmann G; Jacobi V; Zeuzem S
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
The American journal of gastroenterology 1999;94(11):3314-9.
1999: Brieger A; Trojan J; Raedle J; Roth W K; Zeuzem S
Identification of germline mutations in hereditary nonpolyposis colorectal cancer using base excision sequence scanning analysis.
Clinical chemistry 1999;45(9):1564-7.
1999: Hoffmann R M; Berg T; Teuber G; Prümmer O; Leifeld L; Jung M C; Spengler U; Zeuzem S; Hopf U; Pape G R
Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C.
Zeitschrift für Gastroenterologie 1999;37(8):715-23.
1999: Sarrazin C; Zeuzem S
[Interferon-alpha plus ribavirin combination therapy in chronic hepatitis C]
Zeitschrift für Gastroenterologie 1999;37(7):669-74.
1999: Dietrich C F; Leuschner M S; Zeuzem S; Herrmann G; Sarrazin C; Caspary W F; Leuschner U F
Peri-hepatic lymphadenopathy in primary biliary cirrhosis reflects progression of the disease.
European journal of gastroenterology & hepatology 1999;11(7):747-53.
1999: Sarrazin C; Berg T; Lee J H; Teuber G; Dietrich C F; Roth W K; Zeuzem S
Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy.
Journal of hepatology 1999;30(6):1004-13.
1999: Stryjek-Kaminska D; Ochsendorf F; Röder C; Wolter M; Zeuzem S
Photoallergic skin reaction to ribavirin.
The American journal of gastroenterology 1999;94(6):1686-8.
1999: Zeuzem S
[Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C]
Deutsche medizinische Wochenschrift (1946) 1999;124(20):636-42.
1999: Raedle J; Brieger A; Trojan J; Hardt T; Herrmann G; Zeuzem S
Evaluation of rapid microsatellite analysis of paraffin-embedded specimens in screening for hereditary nonpolyposis colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(5):485-91.
1999: Trojan J; Raedle J; Zeuzem S
[Pathogenetic germ-line mutation in patients with hereditary nonpolyposis colorectal carcinoma (HNPCC)]
Zeitschrift für Gastroenterologie 1999;37(4):321-4.
1999: Zeuzem S; Hopf U; Carreno V; Diago M; Shiffman M; Grüne S; Dudley F J; Rakhit A; Rittweger K; Yap S H; Koff R S; Thomas H C
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 1999;29(4):1280-7.
1999: Dietrich C F; Wehrmann T; Zeuzem S; Braden B; Caspary W F; Lembcke B
[Analysis of hepatic echo patterns in chronic hepatitis C]
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 1999;20(1):9-14.
1999: Dietrich C F; Zeuzem S
[Sonographic detection of perihepatic lymph nodes: technique and clinical value]
Zeitschrift für Gastroenterologie 1999;37(2):141-51.
1999: Gebhardt R; Phper A; Zeuzem S
[Regulated exocytosis: Ca(2+)-sensor in exocrine cells?]
Zeitschrift für Gastroenterologie 1999;37(1):121-4.
1999: Trojan J; Brieger A; Raedle J; Roth W K; Zeuzem S
Peutz-Jeghers syndrome: molecular analysis of a three-generation kindred with a novel defect in the serine threonine kinase gene STK11.
The American journal of gastroenterology 1999;94(1):257-61.
1999: Zeuzem S
Clinical implications of hepatitis C viral kinetics.
Journal of hepatology 1999;31 Suppl 1():61-4.
1999: Konrad T; Vicini P; Zeuzem S; Toffolo G; Briem D; Lormann J; Herrmann G; Wittmann D; Lenz T; Kusterer K; Teuber G; Cobelli C; Usadel K H
Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(6):343-9.
1998: Dietrich C F; Zeuzem S; Caspary W F; Wehrmann T
[Ultrasound lymph node imaging in the abdomen and retroperitoneum of healthy probands]
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 1998;19(6):265-9.
1998: Sarrazin C; Roth W K; Zeuzem S
[GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance]
Zeitschrift für Gastroenterologie 1998;36(11):997-1008.
1998: Davis G L; Esteban-Mur R; Rustgi V; Hoefs J; Gordon S C; Trepo C; Shiffman M L; Zeuzem S; Craxi A; Ling M H; Albrecht J
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
The New England journal of medicine 1998;339(21):1493-9.
1998: Trojan J; Raedle J; Zeuzem S
[Mutated serine-threonine kinase gene (STK11) is the cause of Peutz-Jeghers syndrome]
Zeitschrift für Gastroenterologie 1998;36(9):871-3.
1998: Raedle J; Brieger A; Trojan J; Herrmann G; Zeuzem S
Rapid microsatellite analysis of paraffin embedded tumour specimens from patients with hereditary non-polyposis colorectal cancer.
Journal of clinical pathology 1998;51(8):621-2.
1998: Dietrich C F; Lee J H; Gottschalk R; Herrmann G; Sarrazin C; Caspary W F; Zeuzem S
Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C.
AJR. American journal of roentgenology 1998;171(2):437-43.
1998: Raedle J; Oremek G; Truschnowitsch M; Lorenz M; Roth W K; Caspary W F; Zeuzem S
Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma.
European journal of cancer (Oxford, England : 1990) 1998;34(8):1198-203.
1998: Trojan J; Raedle J; Zeuzem S
Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
Digestion 1998;59 Suppl 2():72-4.
1998: Lee J H; von Wagner M; Roth W K; Teuber G; Sarrazin C; Zeuzem S
Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus.
Journal of hepatology 1998;29(1):29-35.
1998: Zeuzem S; Schmidt J M; Lee J H; von Wagner M; Teuber G; Roth W K
Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Hepatology (Baltimore, Md.) 1998;28(1):245-52.
1998: Franke A; Zeuzem S
[Natural course and progression of liver cirhosis in patients with hepatitis C]
Zeitschrift für Gastroenterologie 1998;36(6):539-41.
1998: Zeuzem S; Lee J H; Franke A; Rüster B; Prümmer O; Herrmann G; Roth W K
Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.
Hepatology (Baltimore, Md.) 1998;27(4):1149-56.
1998: Raedle J; Brieger A; Zeuzem S
[Blood oncogene detection in patients with colorectal carcinoma]
Zeitschrift für Gastroenterologie 1998;36(3):257-9.
1998: Zeuzem S
[Glycyrrhizin for the treatment of allergic diseases and chronic hepatitis]
Deutsche medizinische Wochenschrift (1946) 1998;123(12):372.
1998: Roth W K; Lee J H; Rüster B; Zeuzem S
Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method.
Zeitschrift für Gastroenterologie 1998;36(1):5-11.
1997: Lutz M P; Piiper A; Gaisano H Y; Stryjek-Kaminska D; Zeuzem S; Adler G
Protein tyrosine phosphorylation in pancreatic acini: differential effects of VIP and CCK.
The American journal of physiology 1997;273(6 Pt 1):G1226-32.
1997: Sarrazin C; Zeuzem S
[The clinical relevance of the GB virus C/hepatitis G virus]
Zeitschrift für Gastroenterologie 1997;35(11):1031-3.
1997: Lee J H; Stripf T; Roth W K; Zeuzem S
Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism.
Journal of medical virology 1997;53(3):245-51.
1997: Piiper A; Stryjek-Kaminska D; Klengel R; Zeuzem S
Epidermal growth factor inhibits bombesin-induced activation of phospholipase C-beta1 in rat pancreatic acinar cells.
Gastroenterology 1997;113(5):1747-55.
1997: Dietrich C F; Gottschalk R; Herrmann G; Caspary W F; Zeuzem S
[Sonographic detection of lymph nodes in the hepatoduodenal ligament]
Deutsche medizinische Wochenschrift (1946) 1997;122(42):1269-74.
1997: Zeuzem S; de Man R A; Honkoop P; Roth W K; Schalm S W; Schmidt J M
Dynamics of hepatitis B virus infection in vivo.
Journal of hepatology 1997;27(3):431-6.
1997: Piiper A; Stryjek-Kaminska D; Illenberger D; Klengel R; Schmidt J M; Gierschik P; Zeuzem S
Synthetic peptides containing a BXBXXXB(B) motif activate phospholipase C-beta1.
The Biochemical journal 1997;326 ( Pt 3)():669-74.
1997: Dietrich C F; Lee J H; Herrmann G; Teuber G; Roth W K; Caspary W F; Zeuzem S
Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 1997;26(2):467-72.
1997: Raedle J; Oremek G; Roth W K; Caspary W F; Zeuzem S
Anti-p53 autoantibodies in hepatitis C virus-infected patients.
Anticancer research 1997;17(4B):3079-81.
1997: Klengel R; Piiper A; Pittelkow S; Zeuzem S
Differential expression of Rab3 isoforms during differentiation of pancreatic acinar cell line AR42J.
Biochemical and biophysical research communications 1997;236(3):719-22.
1997: Lee J H; Roth W K; Zeuzem S
Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays.
Journal of hepatology 1997;26(5):1001-9.
1997: Piiper A; Stryjek-Kaminska D; Zeuzem S
Epidermal growth factor activates phospholipase C-gamma 1 via G(i)1-2 proteins in isolated pancreatic acinar membranes.
The American journal of physiology 1997;272(5 Pt 1):G1276-84.
1997: Zeuzem S; Lee J H; Roth W K
Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Hepatology (Baltimore, Md.) 1997;25(3):740-4.
1997: Piiper A; Stryjek-Kaminska D; Klengel R; Zeuzem S
CCK, carbachol, and bombesin activate distinct PLC-beta isoenzymes via Gq/11 in rat pancreatic acinar membranes.
The American journal of physiology 1997;272(1 Pt 1):G135-40.
1996: Zeuzem S; Franke A; Lee J H; Herrmann G; Ruster B; Roth W K
Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
Hepatology (Baltimore, Md.) 1996;24(5):1003-9.
1996: Raedle J; Oremek G; Welker M; Roth W K; Caspary W F; Zeuzem S
p53 autoantibodies in patients with pancreatitis and pancreatic carcinoma.
Pancreas 1996;13(3):241-6.
1996: Stryjek-Kaminska D; Piiper A; Zeuzem S
Epidermal growth factor regulates adenylate cyclase activity via Gs and Gi1-2 proteins in pancreatic acinar membranes.
The Biochemical journal 1996;316 ( Pt 1)():87-91.
1996: Piiper A; Stryjek-Kaminska D; Gebhardt R; Zeuzem S
Pertussis toxin-sensitive G-proteins inhibit fibroblast growth factor-induced signaling in pancreatic acini.
Journal of cellular physiology 1996;167(1):52-9.
1996: Roth W K; Lee J H; Rüster B; Zeuzem S
Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays.
Journal of clinical microbiology 1996;34(2):261-4.
1996: Rüster B; Zeuzem S; Roth W K
Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma.
Biochemical and biophysical research communications 1996;219(3):911-5.
1996: Stein J; Purschian B; Zeuzem S; Lembcke B; Caspary W F
Quantification of fecal carbohydrates by near-infrared reflectance analysis.
Clinical chemistry 1996;42(2):309-12.
1996: Stein J; Jung M; Sziegoleit A; Zeuzem S; Caspary W F; Lembcke B
Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function.
Clinical chemistry 1996;42(2):222-6.
1996: Zeuzem S; Schmidt J M; Lee J H; Rüster B; Roth W K
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
Hepatology (Baltimore, Md.) 1996;23(2):366-71.
1996: Zeuzem S; Teuber G; Lee J H; Rüster B; Roth W K
Risk factors for the transmission of hepatitis C.
Journal of hepatology 1996;24(2 Suppl):3-10.
1995: Zeuzem S; Ruster B; Lee J H; Stripf T; Roth W K
Evaluation of a reverse hybridization assay for genotyping of hepatitis C virus.
Journal of hepatology 1995;23(6):654-61.
1995: Raedle J; Roth W K; Oremek G; Caspary W F; Zeuzem S
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Digestive diseases and sciences 1995;40(12):2587-94.
1995: Sahm S W; Zeuzem S; Caspary W F
[Hereditary non-polyposis colon carcinoma. Syndrome of the cancer family--a neglected disease]
Deutsche medizinische Wochenschrift (1946) 1995;120(47):1631-5.
1995: Stryjek-Kaminska D; Piiper A; Zeuzem S
EGF inhibits secretagogue-induced cAMP production and amylase secretion by Gi proteins in pancreatic acini.
The American journal of physiology 1995;269(5 Pt 1):G676-82.
1995: Stein J; Gerhard R; Zeuzem S; Caspary W F
Subcellular distribution of small GTP-binding proteins in the intestinal cell line Caco-2.
European journal of clinical investigation 1995;25(10):793-5.
1995: Piiper A; Stryjek-Kaminska D; Jahn R; Zeuzem S
Stimulation of inositol 1,4,5-trisphosphate production by peptides corresponding to the effector domain of different Rab3 isoforms and cross-linking of an effector domain peptide target.
The Biochemical journal 1995;309 ( Pt 2)():621-7.
1995: Stryjek-Kaminska D; Piiper A; Stein J; Caspary W F; Zeuzem S
Epidermal growth factor receptor signaling in rat pancreatic acinar cells.
Pancreas 1995;10(3):274-80.
1995: Milovic V; Stein J; Piiper A; Gerhard R; Zeuzem S; Caspary W F
Characterization of putrescine transport across the intestinal epithelium: study using isolated brush border and basolateral membrane vesicles of the enterocyte.
European journal of clinical investigation 1995;25(2):97-105.
1995: Zeuzem S; Roth W K; Herrmann G
[Viral hepatitis C]
Zeitschrift für Gastroenterologie 1995;33(2):117-32.
1995: Milovic V; Deubner C; Zeuzem S; Piiper A; Caspary W F; Stein J
EGF stimulates polyamine uptake in Caco-2 cells.
Biochemical and biophysical research communications 1995;206(3):962-8.
1995: Rüster B; Zeuzem S; Roth W K
Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript.
Analytical biochemistry 1995;224(2):597-600.
1995: Stryjek-Kaminska D; Piiper A; Caspary W F; Zeuzem S
Epidermal growth factor inhibits hormone- and fibroblast growth factor-induced activation of phospholipase C in rat pancreatic acini.
Peptides 1995;16(1):123-8.
1994: Piiper A; Stryjek-Kaminska D; Zeuzem S
Synthetic Rab3A effector domain peptide stimulates inositol 1,4,5-trisphosphate production in various permeabilized cells.
Biochemical and biophysical research communications 1994;203(2):756-62.
1994: Zeuzem S; Stryjek-Kaminska D; Caspary W F; Stein J; Piiper A
Effect of a Rab3A effector domain-related peptide, CCK, and EGF in permeabilized pancreatic acini.
The American journal of physiology 1994;267(3 Pt 1):G350-6.
1994: Zeuzem S; Rüster B; Roth W K
Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus.
Zeitschrift für Gastroenterologie 1994;32(6):342-7.
1994: Stryjek-Kaminska D; Piiper A; Caspary W F; Zeuzem S
Epidermal growth factor inhibits amylase secretion and activation of phospholipase C in response to calcium-mobilizing secretagogues in rat pancreatic acini.
Zeitschrift für Gastroenterologie 1994;32(4):232-5.
1994: Piiper A; Stryjek-Kaminska D; Stein J; Caspary W F; Zeuzem S
Tyrphostins inhibit secretagogue-induced 1,4,5-IP3 production and amylase release in pancreatic acini.
The American journal of physiology 1994;266(3 Pt 1):G363-71.
1994: Milovic V; Stein J; Ruppert S; Zeuzem S; Caspary W F
Preparation of basolateral membrane vesicles from rat enterocytes: influence of different gradient media.
Physiological research / Academia Scientiarum Bohemoslovaca 1994;43(2):75-81.
1993: Piiper A; Stryjek-Kaminska D; Stein J; Caspary W F; Zeuzem S
A synthetic peptide of the effector domain of rab3A stimulates inositol 1,4,5-trisphosphate production in digitonin-permeabilized pancreatic acini.
Biochemical and biophysical research communications 1993;192(3):1030-6.
1993: Stryjek-Kaminska D; Piiper A; Caspary W F; Zeuzem S
Effect of epidermal growth factor on cholecystokinin-induced amylase release and inositol 1,4,5-trisphosphate production in pancreatic acinar cells.
Biochemical and biophysical research communications 1993;190(1):92-6.
1993: Piiper A; Stryjek-Kaminska D; Stein J; Caspary W F; Zeuzem S
Effects of guanine nucleotides on bombesin-stimulated signal transduction in rat pancreatic acinar cells.
Research in experimental medicine. Zeitschrift für die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie 1993;193(5):323-35.
1992: Zeuzem S; Caspary W F
[Therapy of autonomic diabetic neuropathy of the gastrointestinal tract]
Deutsche medizinische Wochenschrift (1946) 1992;117(35):1323-5.
1992: Zeuzem S; Caspary W F
[Diagnosis of autonomic diabetic neuropathies of the gastrointestinal tract]
Deutsche medizinische Wochenschrift (1946) 1992;117(34):1285-9.
1991: Zeuzem S; Olbrich H G; Seeger C; Kober G; Schöffling K; Caspary W F
Beat-to-beat variation of heart rate in diabetic patients with autonomic neuropathy and in completely cardiac denervated patients following orthotopic heart transplantation.
International journal of cardiology 1991;33(1):105-14.
1991: Haak T; Jungmann E; Neumann M; Zeuzem S; Schwietzer G; Reschke B; Althoff P H; Schöffling K
[The influence of autonomic diabetic neuropathy and human atrial natriuretic peptide on adrenal gland function in postural changes]
Medizinische Klinik (Munich, Germany : 1983) 1991;86(3):138-41, 171.
1990: Zeuzem S; Lembcke B; Hübner K; Schwab V; Caspary W F
[Cystic polyposis of the stomach]
Deutsche medizinische Wochenschrift (1946) 1990;115(17):653-6.
1990: Zeuzem S; Olbrich H G; Haak T; Jungmann E
In vivo evidence that human atrial natriuretic factor-(99-126) (hANF) stimulates parasympathetic activity in man.
European journal of clinical pharmacology 1990;39(1):77-9.

Sign-in to see more